chr16-2083702-C-T

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2

The NM_000548.5(TSC2):​c.3891C>T​(p.Ala1297Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000132 in 1,585,690 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. A1297A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000014 ( 0 hom. )

Consequence

TSC2
NM_000548.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -2.38

Publications

1 publications found
Variant links:
Genes affected
TSC2 (HGNC:12363): (TSC complex subunit 2) This gene is a tumor suppressor gene that encodes the growth inhibitory protein tuberin. Tuberin interacts with hamartin to form the TSC protein complex which functions in the control of cell growth. This TSC protein complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022]
TSC2 Gene-Disease associations (from GenCC):
  • tuberous sclerosis
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • tuberous sclerosis 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, Ambry Genetics
  • lymphangioleiomyomatosis
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • tuberous sclerosis complex
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 16-2083702-C-T is Benign according to our data. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083702-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 413730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.38 with no splicing effect.
BS2
High AC in GnomAdExome4 at 20 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TSC2NM_000548.5 linkc.3891C>T p.Ala1297Ala synonymous_variant Exon 33 of 42 ENST00000219476.9 NP_000539.2 P49815-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TSC2ENST00000219476.9 linkc.3891C>T p.Ala1297Ala synonymous_variant Exon 33 of 42 5 NM_000548.5 ENSP00000219476.3 P49815-1

Frequencies

GnomAD3 genomes
AF:
0.00000657
AC:
1
AN:
152194
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000293
AC:
6
AN:
204718
AF XY:
0.0000364
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000643
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000222
Gnomad OTH exome
AF:
0.000191
GnomAD4 exome
AF:
0.0000140
AC:
20
AN:
1433496
Hom.:
0
Cov.:
32
AF XY:
0.0000127
AC XY:
9
AN XY:
710172
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33252
American (AMR)
AF:
0.00
AC:
0
AN:
39580
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25464
East Asian (EAS)
AF:
0.0000258
AC:
1
AN:
38756
South Asian (SAS)
AF:
0.0000122
AC:
1
AN:
82166
European-Finnish (FIN)
AF:
0.0000199
AC:
1
AN:
50188
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5730
European-Non Finnish (NFE)
AF:
0.0000127
AC:
14
AN:
1098948
Other (OTH)
AF:
0.0000505
AC:
3
AN:
59412
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000657
AC:
1
AN:
152194
Hom.:
0
Cov.:
33
AF XY:
0.0000135
AC XY:
1
AN XY:
74348
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41450
American (AMR)
AF:
0.00
AC:
0
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68022
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Asia WGS
AF:
0.00260
AC:
9
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Tuberous sclerosis 2 Benign:3
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 02, 2025
Myriad Genetics, Inc.
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. -

Tuberous sclerosis syndrome Benign:1
Nov 30, 2023
All of Us Research Program, National Institutes of Health
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Aug 06, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary cancer-predisposing syndrome Benign:1
Mar 29, 2019
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.76
CADD
Benign
0.030
DANN
Benign
0.44
PhyloP100
-2.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs373508609; hg19: chr16-2133703; API